LCRC Invited Speaker Series

(Sponsored CME series)

2009 - 2010 LCRC Seminar Series Schedule

Time & Location:

2nd and 4th Thursday at Noon
Tulane Location:
JBJ - J. Bennett Johnston Building

(or otherwise noted)
1324 Tulane Avenue - Room 403
Map/DIrections - Contact

1st & 3rd Thursday at Noon
LSU Location:
CSRB - Clinical Science Research Building

(or otherwise noted)
533 Bolivar St. - Room 563
Map/Directions - Contact

Schedule 2010 - 2009:

(For LCRC Speakers from 2006 to 2007, Click Here.)

(For LCRC Speakers from 2008 to 2009, Click Here.)

Statement of Need: The purpose of the Louisiana Cancer Research Consortium Grand Rounds is to provide a forum for the physicians in the Consortium in which they will be able to improve their personal competency in designing appropriate treatment protocols for patients presenting with various cancers; foster faculty communication , inter-professional teaming and professionalism; meet the quality improvement guidelines in cancer care; stay abreast of the latest research and developments in cancer.

Target Audience:

Physicians-specialties: Physicians involved in treating cancer
Non-physicians (nurses, allied health, etc.) Allied health professionals in cancer care

Objectives: After participating in this CME Activity, the participant should be better able to:

Critically evaluate the research which relates to the treatment of patient population presenting with cancer in the metro New Orleans area.
Identify benefits and adverse effects of current therapies for cancer treatment.
Describe the mechanisms behind the recommended therapies for treatment of specific cancers.
Analyze data from clinical trials and latest breakthroughs in cancer research.

Accreditation/Designation of Credit: Tulane University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

Tulane University Health Sciences Center designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Tulane University Health Sciences Center presents this activity for educational purposes only and does not endorse any product, content of presentation or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentation is provided solely by presenters who have been selected because of their recognized expertise.

Facilitated by: The Tulane University Health Sciences Center - Center for Continuing Education

Faculty Disclosure: It is the policy of Continuing Education at Tulane University Health Sciences Center to plan and implement all of its educational activities in accordance with the ACCME's Essential Areas and Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME's Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit TM is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity.

Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental or investigational drugs or devices must also be made known to the audience.

2010	Location		Speaker	Title
Jan 14	Tulane	*Charles Sherr, MD, PhD* Member, St. Jude Faculty Department of Genetics and Tumor Cell Biology St. Jude Children's Research Hospital		"Regulation of Cellular Self Renewal by Tumor Suppressor Genes"

Jan 21	LSU	*Terry Van Dyke, PhD* Sara Graham Distinguished Professor Departments of Genetics, Biochemistry and Biophysics Lineberger Comprehensive Cancer Center UNC Chapel Hill School of Medicine		"Mechanistic Discovery in Murine Cancer Models: From Basic Discovery to Clinical Translation"

Jan 28	Tulane	*Phillip Kantoff, MD* Professor of Medicine Department of Medical Oncology Dana Farber Institute Harvard Medical School

Feb 4	LSU	*William H. Matsui, MD* Associate Professor of Oncology Sidney Kimmel Comprehensive Cancer Center John Hopkins University School of Medicine		"Stem Cell Concepts in Cancer"

Feb 25	Tulane	*Ramesh Shivdasani, MD, PhD* Associate Professor of Medicine Dana Farber Institute Harvard Medical School

Mar 4	LSU	*Zena Werb , PhD* Professor and Vice-Chair Department of Anatomy University of California

Mar 11	Tulane	*Bharat Aggarwal, PhD* Department of Experimental Therapeutics University of Texas MD Anderson Cancer Center

Mar 25	Tulane	Francesco DeMayo, PhD Professor Department of Molecular and Cellular Biology Baylor College of Medicine

Apr 8	Tulane	Myles Brown, MD Professor of Medicine Department of Medical Oncology Dana Farber Institute Harvard Medical School

Apr 29	Tulane	*Joyce Slingerland, MD, PhD, FRCP* Director Braman Family Breast Cancer Institute University of Miami Sylvester Comprehensive Cancer Center

May 13	Tulane	Rakesh Kumar, PhD Professor and Chairman George Washington University Medical Center Dept of Biochemistry and Molecular Biology

June 10	Tulane	Jose R. Conejo-Garcia, MD, PhD Assistant Professor, Microbiology and Immunology Assistant Professor of Medicine Dartmouth Medical School

Sept 9	Tulane	Dean Tang, MD, Ph.D Associate Professor Department of Carcinogenesis Science Park -Research Division University of Texas M.D. Anderson Cancer Center

Sept 23	Tulane	*Tim H. M. Huang, PhD* Professor Human Cancer Genetics Program Ohio State University

Oct 14	Tulane	Sara Sukamar, PhD Professor of Oncology and Pathology John Hopkins University School of Medicine McKusick-Nathans Institute of Genetic Medicine

Back to the top

2009	Location		Speaker	Title
Jan 22	Tulane	*Paul A. Wade, PhD* Principal Investigator Eukaryotic Transcriptional Regulation Group National Institute of Environmental Health Sciences		"Epigenetic Regulation in Disease and Development"

Jan 29	Tulane	*Jianming Xu, PhD* Associate Professor Dept of Molecular and Cellular Biology Baylor College of Medicine		"Detrimental Contributions and Mechanisms of the p160 SRC Family in Breast & Prostate Tumorigenesis and Metastasis"

Feb 5	LSU	*Danny R. Welch, PhD* Professor of Pathology, Cell Biology, and Pharmacology University of Alabama at Birmingham		"Does the Mechanism of Action of Metastasis Suppressors Identify Targets for Cancer Therapeutics?"

Feb 26	Tulane	*Yiping Chen, PhD* Professor Department of Cell and Molecular Biology Tulane University		"Molecular Regulation of Palate Development & Cleft Palate Formation"

Mar 26	Tulane	*Michelle Barton, PhD* Associate Professor Department of Biochemistry and Molecular Biology MD Anderson Cancer Center		"TAP-ing Into p53 Funcitons in Normal Cells"

Apr 2	Tulane	*Christopher C. Benz, MD* Professor and Program Director Adjunct Professor of Medicine Buck Institute for Age Research		"New Biomarker and Therapeutic Approaches to Breast Cancer"

Apr 2	LSU	*Ching-Hon Pui, MD* Member, St. Jude Faculty Chair, Department of Oncology St. Jude Children's Research Hospital		"Recent Advances in Acute Lymphoblastic Leukemia"

Apr 9	Tulane	*Sendurai Mani, PhD* Principal Investigator Department of Molecular Pathology MD Anderson Cancer Center		"Generation of Stem-Like Cells via EMT; A New Twist on Cancer Initiation and Progression"

Apr 16	LSU	*Thao P. Dang, MD* Assistant Professor of Medicine Division of Hematology and Oncology Vanderbilt-Ingram Cancer Center		"Notch3 in Lung Cancer: From the Bedside to the Bench"

Apr 17	Tulane	*Jos Jonkers, PhD* Principal Investigator Division of Molecular Biology The Netherlands Cancer Institute		"Conditional Mouse Models of Breast Cancer"

Apr 21	Tulane	*Robert Cardiff, MD, PhD* Director, Center for Genomic Pathology Dept. of Pathology and Lab. Medicine UC Davis School of Medicine		"Post-Genomic Oncology and One Medicine: Lessons from the Mouse"

Apr 23	Tulane	*Michael F. Clarke, MD* Associate Director Stanford Institute for Stem Cell and Regenerative Medicine Stanford School of Medicine		"Stem Cell Signaling, Self Renewal and Cancer"

May 7	LSU	*E. Premkumar Reddy, PhD* Director, Fels Institute for Cancer Research and Molecular Biology Temple University School of Medicine		"Chemical Biological Approaches for Cancer Therapy"

May 14	Tulane	*Jonathan Melamed, MD* Associate Professor Department of Pathology MYU Langone Medical Center		"Prostate Cancer Biospecimen Banking: The Experience of the CPCTR (Cooperative Prostate Cancer Tissue Resource)"

May 28	LSU	*Jan K. Kitajewski, PhD* Associate Professor of Clinical Pathology Department of Pharmacology ACNC - Audobon		"Notch Functions in Angiogenesis by Diverse Mechanisms"

Jun 4	LSU	*Lily Wu, MD, PhD* Associate Professor Department of Molecular and Medical Pharmacology David Geffen School of Medicine at UCLA		"Functional Molecular Imaging of Cancer Nodal Metastasis"

Jun 11	Tulane	*Scott Hiebert, PhD* Professor of Biochemistry and Medicine Department of Biochemsitry Vanderbilt University		"Role of Histone Deacetylase 3 in Genomic Stability, Transcriptional Control & Cancer Therapy"

Jul 9	Tulane	*Shiuan Chen, PhD* Director, Tumor Cell Biology Department of Surgical Research Beckman Research Institute		"Mechanisms of Endocrine Resistance"

Jul 23	Tulane	*Marcus Peter, PhD* Professor Ben May Dept. for Cancer Research University of Chicago		"The Role of miRNAs in Tumor Progression"

Jul 30	Tulane	*Jin Yang, PhD* Assistant Professor Department of Pharmacology University of California, San Diego		"Exploring a New Twist on Tumor Metastasis"

Aug 13	Tulane	*Wayne Backes, PhD* Associate Dean for Research Professor, Department of Pharmacology LSU Health Sciences Center		"Does the Crowding of Multiple P450's into Membranes Affect Their Functions?"

Sept 10	Tulane	*Ann Nardulli, PhD* Professor Department of Molecular and Integrative Physiology University of Illinois at Urbana-Champaign		"Regulation of Estrogen Responsive Genes"

Oct 8	Tulane	Margaret A. Shupnik, PhD Professor Endocrinology, Molecular Physiology and BIological Physics University of Virginia Health System		"Estrogen Receptor Signaling in Breast Cancer - Sculpting Responses to ER-Targeted Therapies"

Oct 22	Tulane	*Bryan R. Cullen, PhD* James B. Duke Professor Dept of Molecular Genetics and Microbiology Duke University Medical Center		"Viruses, microRNAs and RNA Interference"

Oct 29	Tulane	Wei Xu, PhD Assistant Professor of Oncology McArdle Laboratory for Cancer Research University of Wisconsin-Madison		"Regulation of ERα Transcriptional Network by ERβ and CARM1"

Nov 5	LSU	*Hua Yu, PhD* Professor Cancer Immunotherapeutics & Tumor Immunology City of Hope Comprehensive Cancer Center		"Role of Stat3 in Cancer Inflammation and Tumor Immunity"

Nov 12	Tulane	*Suzanne Fuqua, PhD* Professor Department of Medicine and Molecular and Cellular Biology Baylor College of Medicine		"Mechanisms of Endocrine Resistance in Breast Cancer"

Dec 4	LSU	*Filipe Samaniego, MD* Associate Professor Department of Lymphoma/Melanoma M.D. Anderson Cancer Center University of Texas		"Regulation of Fas in Cancer"

Dec 10	Tulane	*Sonia M. Najjar, PhD* Professor Department of Physiology and Pharmacology University of Toledo

Dec 17	LSU	*George C. Prendergast, PhD* Professor Department of Pathology, Anatomy, and Cell Biology Thomas Jefferson University		"Genetic Regulation and Therapeutic Inhibition of IDO in Immune Escape in Cancer"